ATNX (ATNX) Stock Price, News & Analysis
Company Description
ATNX (NASDAQ: ATNX) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector and carries a market capitalization of $2.3M.
This page collects what Stock Titan holds for ATNX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
ATNX has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, stock split, conferences. View all ATNX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ATNX Company Profile & Sector Positioning
ATNX (ATNX) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing ATNX often look at related companies in the same sector, including Mallinckrodt Plc (MNKKQ), (CADMF), CHINA INFRASTRUCTURE CONSTRUCTI (CHNC), Vencanna Ventures (TPPRF), and Nuvo Pharmaceuticals Inc (MRVFF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ATNX's relative position within its industry.